Maxx Orthopedics Announces Freedom Knee® System Receives US FDA Clearance of Cementless Press-Fit Femoral Component

Share Article

The Freedom Cementless Femoral Component was created using a unique multi-layer porous coating intended to combine the “scratch fit” of plasma spray for initial stability, the high porosity of metallic foams for bone ingrowth, and the cost effectiveness of sintered beaded coatings. This component provides surgeons the option to implant the Freedom Knee without the use of cement on the femoral side and is preferred by some surgeons for their younger patients.

Freedom Cementless Femoral Component

"We aim to restore patient mobility while maximizing bone conservation, and this press-fit option is another product that accomplishes these goals." said Ashesh Shah, CEO, Maxx Medical.

Maxx Orthopedics, Inc. the U.S. subsidiary of Maxx Medical, Pvt. Ltd., a rapidly expanding global orthopedics device company, today announced that it has received US FDA clearance for its Freedom Cementless Femoral Component, the latest addition to its Freedom Knee® System.

The Freedom Cementless Femoral Component was created using a unique multi-layer porous coating intended to combine the “scratch fit” of plasma spray for initial stability, the high porosity of metallic foams for bone ingrowth, and the cost effectiveness of sintered beaded coatings. This component provides surgeons the option to implant the Freedom Knee without the use of cement on the femoral side, and is preferred by some surgeons for their younger patients.

“We are excited about the approval of the latest extension to our Freedom Knee® System as we continue to deliver innovative products that provide better fit and improved outcomes for our patients and medical professionals. We aim to restore patient mobility while maximizing bone conservation, and this press-fit option is another product that accomplishes these goals. The Freedom Cementless Femoral Component will be available for limited release in 2015, with general release occurring in 2016,” said Ashesh Shah, CEO, Maxx Medical.

Launched in 2009, The Freedom Knee® System is a total knee replacement system engineered for high flexion, bone conservation and advanced component size and fit capabilities. Freedom Knee® has US FDA, Drugs Controller General of India (DCGI), European CE Mark, and State Food and Drug Administration P.R. China approvals.

About Maxx Medical Maxx Medical Pvt. Ltd. ("Maxx Medical") develops and markets innovative orthopedic medical devices on an international scale. The company is focused on providing state-of-the-art implants and related solutions that best restore patient mobility while accommodating lifestyle, anatomical and economic needs. Maxx Medical is the parent company of Maxx Orthopedics, Inc., the manufacturer of the Freedom Knee® System. For additional information visit http://www.maxxmed.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

S.Bond
Maxx Medical
+1 484.342.0092 Ext: 502
Email >
Visit website